Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Müller HD, Posch F, Suppan C, Bargfrieder U, Gumpoldsberger M, Hammer R, Hauser H, Dandachi N, Prein K, Stoeger H, Lax S, Balic M.
Müller HD, et al. Among authors: hammer r.
Ann Surg Oncol. 2019 Dec;26(13):4274-4283. doi: 10.1245/s10434-019-07741-w. Epub 2019 Aug 26.
Ann Surg Oncol. 2019.
PMID: 31452052
Free PMC article.